Key result
Carotid baroreceptor stimulation is a potential therapeutic approach for long-term blood pressure regulation, though baroreflexes act in concert with other control systems.
Why the study?
Does carotid baroreceptor stimulation lower blood pressure in patients with hypertension?
Does carotid baroreceptor stimulation lower blood pressure in patients with hypertension?
Answers are grounded in this paper and cite their sources.
Carotid baroreceptor stimulation via devices like Rheos represents a potential therapeutic approach for hypertension, though its long-term efficacy and role among other blood pressure control systems require further clarification.
BACKGROUND: The role of the carotid baroreflex in blood pressure regulation has been known for a long time but its effects were thought to be short lived. Recent data indicate that stimulation of carotid baroreceptors may lower blood pressure not only for short periods of time, but also in the long run. OBJECTIVE/METHODS: Recent advances in technology permitted the development of a new device (Rheos) that addresses problems with older devices. Several questions remain to be addressed before Rheos can be used widely, and several potential clinical applications remain to be clarified. This review examines these issues and comprehensively describes this therapeutic approach. RESULTS/CONCLUSIONS: The carotid baroreceptor reflex is probably not completely in control of blood pressure. Baroreflexes are one of many control systems acting in concert.
No takes yet. Share an insight, caveat, or question.
Doumas et al. (2009) conducted a review in Hypertension and other cardiovascular conditions. Carotid baroreceptor stimulation (Rheos device) was evaluated. Carotid baroreceptor stimulation is a potential therapeutic approach for long-term blood pressure regulation, though baroreflexes act in concert with other control systems.
Synapse has enriched 10 related papers. Consider them for comparative context: